-

03:46:03 PM

LIVE Real Time ZOM Stock Market News

ZOM - Zomedica Corp

04/15/21 6:01 AM

AMEX : ZOM

Zomedica to Build Direct Sales Force for TRUFORMA(R) Platform

Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that it intends to expand its direct sales organization while phasing out

RHEA-AI

neutral

03/16/21 6:00 AM

AMEX : ZOM

Zomedica Announces First Commercial Sale of Its Truforma(R) Platform

Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, yesterday recorded the first veterinarian sale of TRUFORMA (R) and officially entered

RHEA-AI

neutral

03/08/21 6:05 AM

AMEX : ZOM

Zomedica Retires Preferred Shares

Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has effected

RHEA-AI

neutral

02/26/21 4:15 PM

AMEX : ZOM

Zomedica Corp. Announces Year End 2020 Financial Results

Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the year ended December 31, 2020.

RHEA-AI

neutral

02/16/21 11:37 AM

AMEX : ZOM

Zomedica Corp. Announces Full Exercise of Over-Allotment Option by Underwriter

Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that the underwriter of its previously announced public offering of

RHEA-AI

neutral

02/11/21 12:18 PM

AMEX : ZOM

Zomedica Corp. Announces Closing of $173.5 Million Bought Deal

Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that the closing of its previously announced public offering of

RHEA-AI

neutral

02/08/21 11:00 PM

AMEX : ZOM

Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million

Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, due to demand, the underwriter has agreed to increase the size

RHEA-AI

neutral

02/08/21 5:01 PM

AMEX : ZOM

Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares

Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has entered into an underwriting agreement with H.C.

RHEA-AI

neutral

01/25/21 6:10 AM

AMEX : ZOM

Zomedica Signs TRUFORMA(TM) Distribution Agreement With Miller Veterinary Supply

Zomedica Corp. (NYSE American: ZOM) ("Zomedica"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has signed an agreement with Miller Veterinary Supply ("Miller") for the

RHEA-AI

very positive

01/18/21 6:15 AM

AMEX : ZOM

Zomedica CEO Issues Shareholder Letter as TRUFORMA(TM) Nears Commercialization

Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today issued the following letter from Robert Cohen, Chief Executive Officer, updating

RHEA-AI

neutral